A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
Pfizer
Pfizer
Tizona Therapeutics, Inc
Turning Point Therapeutics, Inc.
Numab Therapeutics AG
Novartis
Imugene Limited
Ikena Oncology
Ikena Oncology
Multitude Therapeutics Inc.
Cantargia AB
Innovent Biologics (Suzhou) Co. Ltd.
Novartis
MacroGenics
Bayer
Bayer
Esanex Inc.
Pharmacyclics LLC.